Gnanagurudasan Prakasam, MD MRCP MHA

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Novo Nordisk
    Topic:
    Growth hormone
    Date added:
    01/20/2023
    Date updated:
    10/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Lilly
    Topic:
    diabetes
    Date added:
    08/24/2023
    Date updated:
    10/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Abbvie
    Topic:
    Puberty
    Date added:
    08/24/2023
    Date updated:
    10/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Mannkind
    Topic:
    Inhaled insulin
    Date added:
    02/11/2024
    Date updated:
    10/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Alexion
    Topic:
    HPP
    Date added:
    02/11/2024
    Date updated:
    10/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    K Kirin
    Topic:
    XLH
    Date added:
    02/11/2024
    Date updated:
    10/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Neurocrine
    Topic:
    CAH
    Date added:
    04/27/2025
    Date updated:
    10/27/2025
Return to 0688_SMCS_Pediatric Type 1 Diabetes and Coordinated Care Delivery Conference_Live